A North Carolina-based biotech company is seeing some premarket action on Tuesday after the company announced the final results from the Phase 2 VIBRANT study of vurolenatide in...

To read the full story on AllPennyStocks.com, click here.

9 Meters Biopharma (NASDAQ:NMTR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more 9 Meters Biopharma Charts.
9 Meters Biopharma (NASDAQ:NMTR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more 9 Meters Biopharma Charts.